Literature DB >> 20606687

Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Oliver Steiner1, Caroline Coisne, Britta Engelhardt, Ruth Lyck.   

Abstract

Important insights into the molecular mechanism of T cell extravasation across the blood-brain barrier (BBB) have already been obtained using immortalized mouse brain endothelioma cell lines (bEnd). However, compared with bEnd, primary brain endothelial cells have been shown to establish better barrier characteristics, including complex tight junctions and low permeability. In this study, we asked whether bEnd5 and primary mouse brain microvascular endothelial cells (pMBMECs) were equally suited as in vitro models with which to study the cellular and molecular mechanisms of T cell extravasation across the BBB. We found that both in vitro BBB models equally supported both T cell adhesion under static and physiologic flow conditions, and T cell crawling on the endothelial surface against the direction of flow. In contrast, distances of T cell crawling on pMBMECs were strikingly longer than on bEnd5, whereas diapedesis of T cells across pMBMECs was dramatically reduced compared with bEnd5. Thus, both in vitro BBB models are suited to study T cell adhesion. However, because pMBMECs better reflect endothelial BBB specialization in vivo, we propose that more reliable information about the cellular and molecular mechanisms of T cell diapedesis across the BBB can be attained using pMBMECs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606687      PMCID: PMC3049495          DOI: 10.1038/jcbfm.2010.96

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  42 in total

1.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Differential expression of selectins by mouse brain capillary endothelial cells in vitro in response to distinct inflammatory stimuli.

Authors:  Caroline Coisne; Christelle Faveeuw; Yannick Delplace; Lucie Dehouck; Florence Miller; Roméo Cecchelli; Bénédicte Dehouck
Journal:  Neurosci Lett       Date:  2005-10-07       Impact factor: 3.046

3.  Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium.

Authors:  Caroline Coisne; Lucie Dehouck; Christelle Faveeuw; Yannick Delplace; Florence Miller; Christophe Landry; Céline Morissette; Laurence Fenart; Romeo Cecchelli; Patrick Tremblay; Bénédicte Dehouck
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

4.  Epithelial transport and barrier function in occludin-deficient mice.

Authors:  J D Schulzke; A H Gitter; J Mankertz; S Spiegel; U Seidler; S Amasheh; M Saitou; S Tsukita; M Fromm
Journal:  Biochim Biophys Acta       Date:  2005-05-15

Review 5.  VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.

Authors:  Dietmar Vestweber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-27       Impact factor: 8.311

Review 6.  Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees.

Authors:  Elisabetta Dejana; Fabrizio Orsenigo; Cinzia Molendini; Peter Baluk; Donald M McDonald
Journal:  Cell Tissue Res       Date:  2008-10-15       Impact factor: 5.249

7.  T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells.

Authors:  Y Reiss; G Hoch; U Deutsch; B Engelhardt
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

8.  Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration.

Authors:  Patric Turowski; Roberta Martinelli; Rebecca Crawford; David Wateridge; Anna-Pia Papageorgiou; Maria Grazia Lampugnani; Alexander C Gamp; Dietmar Vestweber; Peter Adamson; Elisabetta Dejana; John Greenwood
Journal:  J Cell Sci       Date:  2008-01-01       Impact factor: 5.285

9.  Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin.

Authors:  Ziv Shulman; Vera Shinder; Eugenia Klein; Valentin Grabovsky; Orna Yeger; Erez Geron; Alessio Montresor; Matteo Bolomini-Vittori; Sara W Feigelson; Tomas Kirchhausen; Carlo Laudanna; Guy Shakhar; Ronen Alon
Journal:  Immunity       Date:  2009-03-05       Impact factor: 31.745

10.  Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium.

Authors:  M B Lawrence; C W Smith; S G Eskin; L V McIntire
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

View more
  38 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

2.  High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.

Authors:  Hisham Qosa; Loqman A Mohamed; Sweilem B Al Rihani; Yazan S Batarseh; Quoc-Viet Duong; Jeffrey N Keller; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

3.  Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier.

Authors:  Be'eri Niego; Robert L Medcalf
Journal:  J Vis Exp       Date:  2013-11-12       Impact factor: 1.355

Review 4.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

5.  Reduced FAK-STAT3 signaling contributes to ER stress-induced mitochondrial dysfunction and death in endothelial cells.

Authors:  Kalpita Banerjee; Matt P Keasey; Vladislav Razskazovskiy; Nishant P Visavadiya; Cuihong Jia; Theo Hagg
Journal:  Cell Signal       Date:  2017-05-08       Impact factor: 4.315

6.  An In Vitro Model of the Blood-brain Barrier Using Impedance Spectroscopy: A Focus on T Cell-endothelial Cell Interaction.

Authors:  Ivan Kuzmanov; Alexander M Herrmann; Hans-Joachim Galla; Sven G Meuth; Heinz Wiendl; Luisa Klotz
Journal:  J Vis Exp       Date:  2016-12-08       Impact factor: 1.355

Review 7.  Stem Cells as a Promising Tool for the Restoration of Brain Neurovascular Unit and Angiogenic Orientation.

Authors:  Mohammad Hossein Geranmayeh; Alireza Nourazarian; Çığır Biray Avci; Reza Rahbarghazi; Mehdi Farhoudi
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

8.  Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells.

Authors:  Simone S E Nielsen; Piotr Siupka; Ana Georgian; Jane E Preston; Andrea E Tóth; Siti R Yusof; N Joan Abbott; Morten S Nielsen
Journal:  J Vis Exp       Date:  2017-09-24       Impact factor: 1.355

9.  ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.

Authors:  Ruth Lyck; Marc-André Lécuyer; Michael Abadier; Christof B Wyss; Christoph Matti; Maria Rosito; Gaby Enzmann; Thomas Zeis; Laure Michel; Ana B García Martín; Federica Sallusto; Fabien Gosselet; Urban Deutsch; Joshua A Weiner; Nicole Schaeren-Wiemers; Alexandre Prat; Britta Engelhardt
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-14       Impact factor: 6.200

Review 10.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.